Video Experimental Relacionado
Updated: Aug 16, 2026
08:46
Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
Published on: May 18, 2016
Protección contra la malaria mediante la vacunación con la proteína de superficie esporozoica 2 más la proteína CS
S Khusmith1, Y Charoenvit, S Kumar
1Malaria Program, Naval Medical Research Institute, Bethesda, MD 20889.
Science (New York, N.Y.)
|May 3, 1991
Resumen
Desarrollar una vacuna completa contra el sporozoito de la malaria requiere apuntar a múltiples antígenos. La combinación de la proteína circumsporozoite (CS) y la proteína de superficie sporozoite 2 (SSP2) en un sistema de administración de vacunas logró una protección completa en ratones.
Área de la Ciencia:
- Inmunología Inmunología.
- Vacunología Vacunología.
- Enfermedades infecciosas Enfermedades infecciosas.
Sus antecedentes:
- La proteína circumsporozoite (CS) es un objetivo primario para el desarrollo de vacunas contra el sporozoite de la malaria.
- Las vacunas de subunidad basadas solo en la proteína CS no han logrado una protección completa.
- La inmunización por esporozoitos irradiados provoca una inmunidad protectora robusta.
Objetivo del estudio:
- Para investigar la eficacia de una vacuna multi-antígeno dirigida a Plasmodium yoelii sporozoites.
- Evaluar el papel de la proteína de superficie de esporozoito 2 (SSP2) en la inmunidad protectora.
- Para comparar la protección inducida por las vacunas de un solo antígeno frente a las de múltiples antígenos.
Principales métodos:
- Inmunización de ratones BALB/c con esporozoitos de Plasmodium yoelii irradiados.
- Generación de anticuerpos y células T citotóxicas contra la proteína CS y SSP2.
- Transfección de células P815 con genes SSP2 y CS para la inmunización.
- Desafiar los estudios para evaluar la protección contra la malaria.
Principales resultados:
- La inmunización por esporozoitos irradiados indujo anticuerpos y células T citotóxicas contra SSP2.
- Los ratones inmunizados con transfectantes SSP2 o CS mostraron una protección parcial.
- Se logró una protección completa en ratones inmunizados con una mezcla de transfectantes SSP2 y CS.
Conclusiones:
- Los sistemas de administración de vacunas son cruciales para lograr una protección completa contra la malaria.
- Una vacuna multi-antígeno esporozoita dirigida tanto a las proteínas SSP2 como a las CS es efectiva.
- Estos hallazgos apoyan el desarrollo de nuevas vacunas contra la malaria basadas en múltiples antígenos esporozoíticos.
Videos de Conceptos Relacionados
00:58Symbiosis
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
01:27Diversity of Protists II
Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...
01:24Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
01:18Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...